Congenital Diaphragmatic Hernia



Subscribe to be notified of changes or updates to this page.

Leveraging CHOP's standing as the largest congenital diaphragmatic hernia (CDH) treatment center in the country, this program aims to become the international epicenter for the care of CDH and to eliminate mortality and morbidity through new research and the development of novel devices. CDH is a structural birth defect in which the diaphragm fails to close, allowing contents from the abdomen to move into the chest and resulting in respiratory distress and a high likelihood of premature death.

The Congenital Diaphragmatic Hernia program received Frontier status for Fiscal Year 2020.